rofecoxib has been researched along with Syndrome in 4 studies
Syndrome: A characteristic symptom complex.
Excerpt | Relevance | Reference |
---|---|---|
"To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up." | 9.11 | Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. ( Dobrzycki, S; Kamiński, KA; Kralisz, P; Kuklińska, AM; Modrzejewski, W; Musiał, WJ; Sobkowicz, B; Stec, S; Wojtkowska, I, 2005) |
"To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up." | 5.11 | Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. ( Dobrzycki, S; Kamiński, KA; Kralisz, P; Kuklińska, AM; Modrzejewski, W; Musiał, WJ; Sobkowicz, B; Stec, S; Wojtkowska, I, 2005) |
"Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism." | 1.31 | Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. ( Farfel, Z; Gurevitz, O; Mayan, H, 2002) |
"Hyperprostaglandin E syndrome/antenatal Bartter syndrome (HPS/aBS) is a congenital salt-losing tubulopathy with an induced expression of cyclooxygenase-2 (COX-2) in the macula densa probably leading to hyperreninemia." | 1.31 | Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. ( Brochhausen, C; Jeck, N; Kömhoff, M; Nüsing, RM; Reinalter, SC; Seyberth, HW; Watzer, B, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mayan, H | 1 |
Gurevitz, O | 1 |
Farfel, Z | 1 |
Monakier, D | 1 |
Mates, M | 1 |
Klutstein, MW | 1 |
Balkin, JA | 1 |
Rudensky, B | 1 |
Meerkin, D | 1 |
Tzivoni, D | 1 |
Kuklińska, AM | 1 |
Musiał, WJ | 1 |
Kamiński, KA | 1 |
Kralisz, P | 1 |
Modrzejewski, W | 1 |
Sobkowicz, B | 1 |
Dobrzycki, S | 1 |
Stec, S | 1 |
Wojtkowska, I | 1 |
Reinalter, SC | 1 |
Jeck, N | 1 |
Brochhausen, C | 1 |
Watzer, B | 1 |
Nüsing, RM | 1 |
Seyberth, HW | 1 |
Kömhoff, M | 1 |
2 trials available for rofecoxib and Syndrome
Article | Year |
---|---|
Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; C-Reactive Protein; Coronary Disease; Cyclooxygenase Inhibitors; Do | 2004 |
Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antichol | 2005 |
2 other studies available for rofecoxib and Syndrome
Article | Year |
---|---|
Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome.
Topics: Adult; Alkalosis; Calcium; Cyclooxygenase Inhibitors; Humans; Hyperaldosteronism; Hypokalemia; Lacto | 2002 |
Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Topics: Adolescent; Adult; Bartter Syndrome; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxyg | 2002 |